The hits just keep coming for the beastly jab.
New report on myocarditis after mRNA Covid vaccines w/verification of cases https://t.co/XXQbyeLiSP @AnnalsofIM
Overall incidence ages 5-39
1st dose: 1 in 200,000
2nd dose: 1 in 30,000
3rd dose: 1 in 50,000
"the benefits of mRNA vaccination greatly outweigh the risk" pic.twitter.com/xKErK7M0EQ— Eric Topol (@EricTopol) October 3, 2022
What’s more, it turns out that VAERS was undercounting incidents of myocarditis after the beastly jab (emphasis ours):
Discussion: In this population-based surveillance, we found that myocarditis/pericarditis 0 to 7 days after mRNA vaccination in persons aged 5 to 39 years occurred in approximately 1 in 200 000 doses after the first dose and 1 in 30 000 doses after second dose of the primary series, and 1 in 50 000 doses after the first booster. The incidence varied markedly by age and sex, however, with a disproportionate number of cases occurring in male persons, notably among adolescents after dose 2 and first boosters.
Our observed incidence after first boosters was generally higher than after dose 1, consistent with reporting from Israel (4). However, in contrast to this earlier report, we did not consistently observe a lower incidence after the first booster than after the second dose in the primary vaccination series. Incidence rates of myocarditis/pericarditis observed in the VSD population were higher, particularly after first boosters, than those reported to the U.S. Vaccine Adverse Event Reporting System (VAERS), but patterns noted by sex and age subgroups were similar (2, 5). Rates from VAERS may be lower because of the passive nature of VAERS reporting versus VSD’s identification of cases using active surveillance. Both VSD and VAERS found incidence rates during days 0 to 7 after vaccination that were higher than the prepandemic background rates noted by Oster and colleagues (2); however, prepandemic rates may not be directly comparable with post vaccination rates because underdiagnosis of myocarditis/pericarditis in this age range was more likely prepandemic than post vaccination when surveillance was greater.
Are you shocked yet? What else was VAERS undercounting?
Another thread on recent studies starts here:
2 new studies have examined the #myocarditis risk after COVID-19 vaccines:
At age <40, #SARSCoV2 carried a ⬆️ risk – apart from Moderna's — not given to ages <30y in e.g. Sweden.
Highest in ages 12-17y for dose 2-3:
~1 case /5320-7300 dosesBut ⬇️ risk with longer interval
? pic.twitter.com/snLdbFWACH— Jonathan Cedernaes (@JCedernaes) October 3, 2022
The science is now speaking, and it’s debunking the SCIENCE!™️
Join the Discussion